Profound Medical Corp. (PROF) Dividend History

Company News

• High Intensity Focused Ultrasound (HIFU) Market to Reach $1.81 Billion by 2034, Growing at a CAGR of 10.4% | Rising Demand for Non-Invasive Therapeutic Solutions Driving Global Market Expansion

  The global HIFU market is expected to grow rapidly over the next decade, driven by the rising demand for non-invasive therapeutic solutions and advancements in imaging technology. Key growth regions include Asia-Pacific and North America.

  GlobeNewswire Inc.
• Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws

  Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential securities fraud after the company disclosed an error that overstated revenue by $472,000 in the first quarter of 2024.

  GlobeNewswire Inc.
• Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

  Profound Medical, a medical device company, will announce its Q4 and full-year 2024 financial results on March 6, 2025, and host a conference call to discuss the results and business developments.

  GlobeNewswire Inc.
• Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

  Profound Medical reported strong preliminary Q4 2024 revenue growth of 105-110% year-over-year, driven by increased adoption of its TULSA-PRO technology. The company will transition to reporting under U.S. GAAP and filing with the SEC on domestic forms to better serve its primarily U.S.-based investor base.

  Benzinga
• Profound Medical Announces Proposed Public Offering of Common Shares

  Profound Medical Corp. announced a proposed public offering of common shares to fund the continued commercialization and development of its TULSA-PRO and Sonalleve systems globally, as well as for working capital and general corporate purposes.

  GlobeNewswire Inc.